Nuvo Pharmaceuticals Inc. (TSX:MRV) is looking for acquisitions. Jesse Ledger said, "Our second pathway to growth is through inorganic business development opportunities. We are actively seeking to in-license new and innovative products that leverage our existing infrastructure, looking to acquire complementary on-market brands that bolt on to this commercial infrastructure and to identify and acquire businesses that provide opportunities to realize synergies on integration into our infrastructure".